glp-1 drugs for weight loss side effects Part 2 of a 3-Part Series; Medications GLP-1 Medications Infographic | Medidex

Description

Hill CJ, Fogarty DG

The effects of DPP4 inhibitors on the immune system are not well understood

A pilot study subsequently conducted by Holst in collaboration with Mette Zander at Hvidovre Hospital between September 1999 and October 2000 indicated that continuous subcutaneous infusions of synthetic GLP-1 over 6 weeks into patients with quite severe type 2 diabetes dramatically improved their blood sugar control, lowered glycated haemoglobin levels and decreased their body weight

Merck, Roche, AstraZeneca, and Lilly all rose in the rankings with Lilly pushing GSK out of the top 10

Potential systemic anti-inflammatory effects could theoretically benefit multiple conditions characterized by chronic low-grade inflammation, including metabolic syndrome, cardiovascular disease, and certain autoimmune conditions